SGK1 and diffuse large B-cell lymphoma: In DLBCL, mutation of SGK1 may lead to its loss of function, rendering lymphoma cells more sensitive to glucocorticoids, chemotherapy drugs, and radiotherapy, thereby improving prognosis.